1-12 of 12
Elizabeth R. Lyden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pre-Hematopoietic Cell Transplantation (HCT) Frailty Is Associated with Lower Cognitive Function and Health-Related Quality of Life (HRQOL) in Older Adults Undergoing HCT

Thuy T Koll, Megan Kerns, Tanya M. Wildes, Vijaya Raj Bhatt, Krishna Gundabolu, Lori Maness, Michael Haddadin, Marcia Free, Elizabeth R Lyden, Daniel L Murman, Alfred L Fisher
Journal: Blood
Blood (2024) 144 (Supplement 1): 3550.
https://doi.org/10.1182/blood-2024-210392
Published: 2024
Journal Articles

Association of Insurance Types and Survival in Acute Promyelocytic Leukemia (APL)

Prajwal Dhakal, Elizabeth R. Lyden, Utsav Joshi, Avantika Pyakuryal, Krishna Gundabolu, Vijaya R. Bhatt
Journal: Blood
Blood (2021) 138 (Supplement 1): 4129.
https://doi.org/10.1182/blood-2021-151055
Published: 2021
Journal Articles

Poor Outcomes of Older Adults with Acute Promyelocytic Leukemia (APL) Regardless of Insurance Types

Prajwal Dhakal, Elizabeth R. Lyden, Utsav Joshi, Avantika Pyakuryal, Krishna Gundabolu, Vijaya R. Bhatt
Journal: Blood
Blood (2021) 138 (Supplement 1): 3065.
https://doi.org/10.1182/blood-2021-150896
Published: 2021
Journal Articles

Thirty-Five Year Follow-up Analysis of Follicular Lymphoma Patients Treated through the Nebraska Lymphoma Study Group: Prognostic Factor Analysis and Outcomes

Amulya Yellala, MBBS, Elizabeth R. Lyden, MS, Heather Nutsch, Avyakta Kallam, MD, Kai Fu, MD PhD, Timothy C. Greiner, MS, MD, Philip Bierman, MD, Matthew A. Lunning, DO, FACP, R. Gregory Bociek, MD, James O. Armitage, MD, Julie M. Vose, MD MBA
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-142743
Published: 2020
Journal Articles

Early Mortality and Overall Survival in Acute Promyelocytic Leukemia: Do Real-World Data Match Results of the Clinical Trials?

Prajwal Dhakal, MBBS, Elizabeth R. Lyden, MS, Venkat Rajasurya, MD, Krishna Gundabolu, MBBS, Chakra P Chaulagain, MD, Vijaya R. Bhatt, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-136186
Published: 2020
Journal Articles

The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma - Single Institution Experience

Madeline Skousen, Sarah A. Holstein, MD PhD, Matthew A. Lunning, DO, FACP, Elizabeth R. Lyden, MS, Gilmore Sheree, BA, Kimberly Schmit-Pokorny, Nurse Manager, James O. Armitage, MD, Zaid S. Al-Kadhimi, MD, Julie M Vose, MDMBA, Muhamed Baljevic, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2028.
https://doi.org/10.1182/blood-2019-131594
Published: 2019
Journal Articles

Prevalence and Effects of Polypharmacy on Overall Survival (OS) of Acute Myeloid Leukemia (AML)

Prajwal Dhakal, MBBS, Elizabeth R. Lyden, MS, Kate-Lynn E Muir, MD, Zaid S. Al-Kadhimi, MD, Thuy T. Koll, MD, Lori J. Maness, MD, Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5086.
https://doi.org/10.1182/blood-2019-124000
Published: 2019
Journal Articles

Phase I/II Study of CHOEP Plus Lenalidomide As Initial Therapy for Patients with Stage II-IV Peripheral T-Cell Lymphoma: Phase II Results

Matthew A. Lunning, DO, Steven M. Horwitz, MD, Ranjana Advani, MD, Julie M. Vose, MDMBA, Hun Ju Lee, MD, Neha Mehta-Shah, MD, Jasmine M. Zain, MD, Bradley M. Haverkos, MD MPH, MS, Mary Jo Lechowicz, MD, Alison J. Moskowitz, MD, Luu Q. Pham, Elizabeth R. Lyden, MS, Peggy Heires, R.N., Stephen M. Ansell, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2899.
https://doi.org/10.1182/blood-2018-99-114110
Published: 2018
Journal Articles

A Single-Center Phase IIa Study Evaluating the Safety and Tolerability of Umbralisib and Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Matthew A. Lunning, DO, Philip Bierman, MD, R. Gregory Bociek, MD, James O. Armitage, MD, Peggy Heires, R.N., Maribeth Hohenstein, R.N, Susan Blumel, RN, Jonathan Tefft, B.A., Elizabeth R. Lyden, MS, Michael R Green, PhD, Julie M. Vose, MD MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 5390.
https://doi.org/10.1182/blood-2018-99-119765
Published: 2018
Journal Articles

Allogeneic Stem Cell Transplantation for Multiple Myeloma: A 34-Year Experience

Courtney Venegas, BA, Matthew A. Lunning, DO, Zaid S. Al-Kadhimi, MD, Vijaya R. Bhatt, MD, Elizabeth R. Lyden, MS, Kimberly Schmit-Pokorny, Nurse Manager, James O. Armitage, MD, Julie M. Vose, MD MBA, Sarah A. Holstein, MD PhD, Muhamed Baljevic, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5780.
https://doi.org/10.1182/blood-2018-99-116990
Published: 2018
Journal Articles

The Association between CD34+ Dose, Platelet Recovery and Incidence of Relapse after Autologous Stem Cell Transplant in Multiple Myeloma

Muhamed Baljevic, MD, Sarah A. Holstein, MD PhD, Matthew A. Lunning, DO, Elizabeth R. Lyden, MS, James O. Armitage, MD, Julie M. Vose, MDMBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 3287.
https://doi.org/10.1182/blood.V130.Suppl_1.3287.3287
Published: 2017
Journal Articles

Treatment Practices in Older Adults with Acute Myeloid Leukemia (AML)

Andrea J. Lee, BS, Elizabeth R. Lyden, MS, Lakshmi Manogna Chintalacheruvu, MD, Thuy Thi Koll, MD, Lori J. Maness, MD, Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5659.
https://doi.org/10.1182/blood.V130.Suppl_1.5659.5659
Published: 2017